Funding Opportunities

This page contains information on current funding opportunities. 

NOW OPEN: 

Leslie Ann Wyman Brain Tumour Research Endowment

  • This award is one-time and to be used toward a trainee's stipend. It's a $18,500 award to support research for the study of brain tumours and their treatment, including new therapies, surgical or otherwise.
  • The deadline to apply is October 30, 2020
  • Your supervisor must be a full member of the Djavad Mowafaghian Centre for Brain Health and you must not hold external (e.g. Tri-agency) or internal (e.g. 4YF) funding exceeding $25,000 per year if you are a graduate student or $50,000 per year if you are a postdoc

More information and the application can be found here. 

 

Dawn Shaw Alzheimer’s Disease Research competition

Eligibility:
Primary applicants must be a full member of the DMCBH; however, co-applicants do not have to be, and we encourage diverse collaborations. 

Objective:
This competition will support research that focuses on outstanding questions related to Alzheimer’s Disease, which could include (but is not limited to) causes of the disease, diagnosis, treatment and experimental models of the disease. A list of successful projects from last year can be viewed on the DMCBH website.

Awards available:
This competition will support up to a maximum of four (4) research awards, each valued at $75,000 for one year. There is a possibility of applying for a second year contingent upon progress and availability of funding. 

How to apply:
Please provide the following information in your application, which should be a maximum of 2 pages:

  • Brief rationale and specific aims of the project
  • A brief project description including methodology
  • Innovation/novelty of the project
  • Project team
  • Budget

A short progress report will be required at the end of the funding period (one year) and awardees will be required to present their findings at the NRSC colloquium. 

Peer review process:
Research proposals will be adjudicated by a committee delegated by the DMCBH Executive and will include a Chair and 3-4 reviewing members. Evaluation criteria will include:

  • Innovation/novelty of approach and research question(s), (especially in the context of PI’s and team’s recent work);
  • Scientific merit and methodological rigour;
  • Evidence of new collaborative interactions/partnerships;
  • Potential impact on the greater understanding & treatment of Alzheimer’s Disease.

Submission & questions:
Please submit completed project proposals to Chris Crossfield (chris.crossfield@ubc.ca) by November 15, 2020. Any questions regarding the application process can also be directed to Chris.